Recombinant Mouse Sphingosine 1-phosphate receptor 5 (S1pr5)

What is S1PR5 and how does it differ from other S1P receptors in immune cell trafficking?

S1PR5 is a G protein-coupled receptor that recognizes sphingosine-1-phosphate and regulates lymphocyte migration. Unlike S1PR1, which is uniformly expressed in naive and circulating memory T cells under KLF2 control, S1PR5 is only induced following antigen experience and is not expressed by naive CD8+ T cells . While both S1PR1 and S1PR5 are downregulated during TRM cell differentiation, they exhibit distinct expression patterns and molecular regulation. Notably, S1PR5 does not interact with CD69 (unlike S1PR1), indicating fundamental differences in how these receptors are regulated . Other S1P receptors (S1PR2, S1PR3, and S1PR4) are similarly expressed across resident and circulating T cell populations, while S1PR1 and S1PR5 are selectively downregulated in TRM cells across multiple tissues .

What is the temporal pattern of S1PR5 expression during T cell differentiation?

S1PR5 expression follows a distinct temporal pattern during T cell activation and differentiation:

• S1PR5 is not detected in naive CD8+ T cells

• Expression is induced in splenic effector T cells as early as 4 days post-infection (dpi)

• Expression increases over time in circulating cells and is maintained in circulating memory T cells for at least 30 days

• Expression diminishes upon T cell entry into peripheral tissues such as skin

• S1PR5 expression is extinguished before the upregulation of the integrin CD103, which marks full acquisition of the TRM cell program

This temporal regulation suggests that S1PR5 downregulation is an early event in TRM precursor development and precedes the complete establishment of tissue residency.

How is S1PR5 expression transcriptionally regulated in T cells?

S1PR5 expression is primarily regulated by a transcriptional cascade involving T-bet and ZEB2:

• T-bet indirectly regulates S1PR5 by activating expression of ZEB2

• ZEB2 then acts as the major proponent of S1PR5 induction

• Forced expression of ZEB2 in effector CD8+ T cells is sufficient to drive S1PR5 upregulation in vitro

• CRISPR/Cas9-mediated ablation of ZEB2 in effector T cells substantially reduces S1PR5 transcripts despite normal expression of T-bet, KLF2, and S1PR1

This regulatory pathway differs from that of S1PR1, which is controlled by KLF2, demonstrating that despite functional similarities, these receptors are governed by distinct transcriptional programs.

How does the T-bet-ZEB2-S1PR5 axis regulate tissue residency of lymphocytes?

The T-bet-ZEB2-S1PR5 axis represents a previously underappreciated mechanism modulating tissue-resident lymphocyte generation:

• T-bet activates expression of ZEB2, which directly induces S1PR5 expression

• Tissue-derived TGF-β promotes downregulation of Tbx21 (encoding T-bet) and Zeb2, which ultimately reduces S1PR5 expression

• Reduced S1PR5 expression hinders tissue traversal and egress, promoting TRM cell formation

• Loss of S1PR5 enhances skin TRM cell formation by promoting peripheral T cell sequestration

• This regulatory mechanism appears to be conserved across both innate and adaptive immune compartments

This axis constitutes a molecular checkpoint that balances peripheral T cell trafficking and TRM cell formation, with S1PR5 downregulation being required for efficient TRM cell differentiation.

What experimental approaches can be used to study S1PR5 function in vivo?

Several experimental approaches have proven valuable for studying S1PR5 function in vivo:

• Retroviral overexpression systems: Using retroviral vectors (RVs) to drive S1PR5 expression in CD8+ T cells, achieving approximately four-fold increases in S1PR5 gene expression compared to physiological levels in effector cells

• Adoptive transfer models: Transferring congenically marked, S1PR5-modified T cells into recipient mice to track their migration and differentiation across tissues

• CRISPR/Cas9 gene editing: Ablating Zeb2 or S1PR5 in effector T cells before transfer into infected mice to study downstream effects on migration and differentiation

• Intravascular labeling: Distinguishing cells located within blood vessels from those in tissue parenchyma to assess S1PR5's impact on vascular retention versus tissue infiltration

• Immunofluorescence imaging: Confirming cellular localization patterns, particularly useful for visualizing redistribution of S1PR5-expressing cells between tissue compartments (e.g., spleen white pulp versus red pulp)

What are the functional consequences of forced S1PR5 expression on T cell localization and TRM formation?

Forced expression of S1PR5 dramatically alters T cell trafficking patterns and impairs TRM cell formation:

• In secondary lymphoid organs:

  • S1PR5-expressing cells are severely underrepresented in lymph nodes

  • In the spleen, S1PR5-expressing cells redistribute from the T cell zone of the white pulp to the red pulp

  • There is increased retention in the vasculature rather than tissue parenchyma

• In peripheral tissues:

  • Reduced numbers of S1PR5-expressing cells infiltrate the skin following inflammatory stimuli

  • Significant reductions in S1PR5-overexpressing CD69+ T cells observed in liver, salivary glands, small intestine, and skin

  • Diminished expression of TRM cell-associated molecules (CD69, CXCR6, CD103) in S1PR5-overexpressing T cells

• Mechanism of impaired tissue localization:

  • These effects are not linked to increased cell death in tissues

  • Rather, they reflect S1PR5-mediated relocalization of cells to the vasculature and enhanced egress from tissues

How should experiments be designed to evaluate S1PR5's role in T cell trafficking?

When designing experiments to study S1PR5's role in T cell trafficking, researchers should consider:

• Model selection: Utilize adoptive transfer models with congenically marked T cells (e.g., CD45.1+) to enable tracking of specific cell populations

• Infection/inflammation models:

  • HSV skin infection model for studying skin TRM formation

  • LCMV-Armstrong infection for studying TRM formation across multiple tissues

  • Contact sensitizer application (e.g., DNFB) to induce T cell migration to skin

• Cellular compartment analysis: Implement intravascular labeling techniques to distinguish cells in the vasculature from those in tissue parenchyma

• Time course considerations: Include multiple time points in analysis (4, 8, 14, 30 days post-infection/transfer) to capture the dynamic nature of S1PR5 expression and T cell differentiation

• Appropriate controls:

  • Use of control retroviral vectors (Ctrl-RV) when performing overexpression experiments

  • Include analysis of multiple tissues to distinguish tissue-specific versus general effects of S1PR5 manipulation

What methodological approaches are effective for manipulating S1PR5 expression in T cells?

Successful manipulation of S1PR5 expression in T cells has been achieved through:

• Retroviral transduction:

  • Retroviral vectors can achieve approximately four-fold increases in S1PR5 expression compared to physiological levels

  • Congenically marked cells can be co-transferred with control cells to directly compare trafficking and differentiation

• CRISPR/Cas9 gene editing:

  • Effective for ablating S1PR5 or its upstream regulators (e.g., Zeb2)

  • Can be performed in effector T cells prior to adoptive transfer

• Transgenic T cell receptor models:

  • gBT-I transgenic CD8+ T cells (specific for HSV epitope gB 498-505) facilitate tracking of antigen-specific responses

  • P14 transgenic CD8+ T cells (specific for LCMV glycoprotein gp33-41) allow analysis of LCMV-specific responses

• In vitro validation:

  • Forced expression of ZEB2 through retroviral transduction can drive S1PR5 upregulation in vitro

  • This approach confirms direct regulatory relationships before proceeding to in vivo studies

How should researchers interpret differences in S1PR5 expression across tissue contexts?

When interpreting S1PR5 expression patterns across different tissues, researchers should consider:

• Tissue architecture differences:

  • The discrepancy between S1PR5 effects in spleen versus lymph nodes may be attributed to distinct tissue architecture

  • The spleen is highly vascularized compared to lymph nodes, which influences cell trafficking patterns

• Temporal dynamics:

  • S1PR5 expression changes over time during the course of infection and memory development

  • Expression levels at day 4 post-infection differ from those at days 14 and 30

• Relationship to other markers:

  • Correlation between S1PR5 downregulation and acquisition of tissue-residency markers (e.g., CD103)

  • S1PR5 expression is extinguished before CD103 upregulation, suggesting sequential programming events

• Species conservation:

  • S1PR5 expression patterns are similar between mouse and human CD8+ T cells

  • Human CD103+ skin TRM cells show extinguished S1PR5, KLF2, and S1PR1 expression compared to circulating memory T cells

What are the proposed mechanisms for S1PR5-mediated regulation of T cell trafficking?

The current understanding of how S1PR5 regulates T cell trafficking involves several mechanisms:

• Inhibition of tissue entry:

  • S1PR5 expression limits cellular homing to lymphoid organs

  • S1PR5 signals inhibit T cell entry into peripheral tissues like skin

• Promotion of tissue exit:

  • S1PR5 promotes T cell egress from peripheral tissues

  • Loss of S1PR5 enhances TRM cell formation by promoting peripheral T cell sequestration

• Altered tissue distribution:

  • In the spleen, S1PR5-expressing cells redistribute from the T cell zone to the red pulp

  • S1PR5 expression is associated with increased vascular retention rather than tissue parenchymal localization

• Integration with other signals:

  • TGF-β signaling in tissues promotes coordinated downregulation of Tbx21, Zeb2, and S1PR5

  • This mechanism harmonizes multiple independent pathways controlling tissue exit and enforces TRM cell commitment

What are the unresolved questions regarding S1PR5 function in immune regulation?

Several important questions remain to be fully addressed:

• Ligand distribution and gradients:

  • How are S1P gradients established and maintained across different tissue compartments?

  • Do local S1P concentrations influence the relative importance of S1PR5 versus S1PR1?

• Cell type-specific functions:

  • While S1PR5 regulates both T cell and NK cell trafficking, are there cell type-specific mechanisms?

  • How does S1PR5 function in other lymphocyte populations beyond CD8+ T cells?

• Therapeutic targeting:

  • Can selective modulation of S1PR5 be achieved without affecting other S1P receptors?

  • Would S1PR5 antagonism enhance TRM formation in vaccination contexts?

• Integration with other migratory receptors:

  • How does S1PR5 signaling interact with chemokine receptor signaling networks?

  • What is the hierarchy of migratory signals when multiple receptors are engaged?

What technical challenges exist in studying S1PR5 function?

Researchers face several technical challenges when investigating S1PR5:

• Antibody limitations:

  • Limited availability of high-quality antibodies for detecting S1PR5 protein expression

  • Reliance on transcript analysis rather than protein detection

• Temporal dynamics:

  • Capturing the dynamic regulation of S1PR5 requires careful time-course experiments

  • Challenge of identifying the precise timing of downregulation in relation to other events

• Tissue-specific effects:

  • Different tissues may exhibit distinct requirements for S1PR5 regulation

  • Need for simultaneous multi-tissue analysis to capture full spectrum of effects

• Functional redundancy:

  • Potential compensatory mechanisms involving other S1P receptors

  • Distinguishing S1PR5-specific effects from broader S1P signaling impacts

How do S1PR5 and S1PR1 compare in their regulation and function?

While S1PR5 and S1PR1 both regulate T cell trafficking and are downregulated during TRM cell differentiation, they exhibit important differences:

This comparison reveals that despite functional similarities in promoting tissue egress, these receptors represent distinct regulatory nodes that are independently controlled yet coordinately downregulated during TRM cell differentiation .

What is the role of TGF-β in coordinating S1PR5 and S1PR1 downregulation?

TGF-β signaling serves as an overarching mechanism that coordinates the downregulation of both S1PR5 and S1PR1, despite their distinct transcriptional regulation:

• TGF-β promotes downregulation of Tbx21 (encoding T-bet) and Zeb2, which ultimately reduces S1PR5 expression

• TGF-β also inhibits KLF2 expression, which reduces S1PR1 levels

• This coordinated downregulation enforces tissue retention and TRM cell commitment

• Local tissue microenvironmental cues, including TGF-β, harmonize these independent pathways controlling tissue exit